Publications by authors named "J Conradie"

Perflorochemicals (PFCs), among which are the most commonly detected perfluorooctanesulfonic acid (PFOS) and perfluorooctanoic acid (PFOA), are persistent emergent contaminants of concern in recent times. These compounds have been reported for their cytotoxicity, genotoxicity, carcinogenicity, immunotoxicity, and developmental toxicities. Meanwhile, they have been detected in diverse matrices such as soil, sediment, and, surprisingly, in serum and even breastmilk.

View Article and Find Full Text PDF

Presented herein is a DFT/TDDFT study of -tetrakis(4-hydroxyphenyl)porphyrin (H[THPP]) and its -deprotonated tetraanionic form; the latter was modeled as both a free tetraanion and with various counterions. Based on our calculations, the experimentally observed hyperporphyrin spectra are attributed to an admixture of phenol/phenoxide character into the a-type HOMO of tetraphenylporphyrin. The admixture results in an elevation of the orbital energy of the HOMO in relation to other frontier orbitals, which accounts for the observed spectral redshifts.

View Article and Find Full Text PDF

Computational electronic structure methods, including ab initio and density functional theory (DFT), have been assessed in calculating the binding energies of 14 five-membered heterocyclic dimers. The configurations were generated using classical molecular dynamics before optimization at the MP2/aug-cc-pVTZ. Benchmark binding energies are calculated at the CCSD(T)/CBS level of theory.

View Article and Find Full Text PDF

The series of iridium(III) complexes, [Ir(ppy)(RCOCHCOR')], with R = CH and R' = CH (), Rc (), and Fc (), as well as R = Rc and R' = Rc () or Fc (), and R = R' = Fc (), ppy = 2-phenylpyridinyl, Fc = Fe(η-CH)(η-CH), and Rc = Ru(η-CH)(η-CH), has been investigated by single-crystal X-ray crystallography and X-ray photoelectron spectroscopy (XPS) supplemented by DFT calculations. Here, in the range of 3.74 ≤ Σχ ≤ 4.

View Article and Find Full Text PDF
Article Synopsis
  • Chronic kidney disease (CKD) poses a major global health challenge, with the study focusing on estimating direct healthcare costs in Australia for non-dialysis patients.
  • Utilizing a comprehensive dataset from Western Australia, the research compared healthcare costs for individuals with CKD to those without, covering various healthcare services and expressing costs in 2023 AUD.
  • Findings revealed that in 2019, CKD accounted for an $8.3 billion cost in Australia, with the highest yearly costs linked to later stages of CKD but a significant number of early-stage cases contributing to the overall financial burden, underscoring the need for effective prevention strategies.
View Article and Find Full Text PDF